4/26
04:19 pm
otlk
Form S-3 Outlook Therapeutics,
Medium
Report
Form S-3 Outlook Therapeutics,
4/17
09:39 pm
otlk
Form SC 13D/A Outlook Therapeutics, Filed by: Syntone Ventures LLC
Medium
Report
Form SC 13D/A Outlook Therapeutics, Filed by: Syntone Ventures LLC
4/17
08:22 pm
otlk
Form 4 Outlook Therapeutics, For: Apr 15 Filed by: Syntone Ventures LLC
Medium
Report
Form 4 Outlook Therapeutics, For: Apr 15 Filed by: Syntone Ventures LLC
4/16
05:22 pm
otlk
Form D Outlook Therapeutics,
Low
Report
Form D Outlook Therapeutics,
4/15
04:54 pm
otlk
Form 8-K Outlook Therapeutics, For: Apr 15
Medium
Report
Form 8-K Outlook Therapeutics, For: Apr 15
4/12
04:27 pm
otlk
Form 424B5 Outlook Therapeutics,
Low
Report
Form 424B5 Outlook Therapeutics,
4/12
04:05 pm
otlk
Form 8-K Outlook Therapeutics, For: Apr 12
Low
Report
Form 8-K Outlook Therapeutics, For: Apr 12
4/8
04:11 pm
otlk
Form SC 13G Outlook Therapeutics, Filed by: GREAT POINT PARTNERS LLC
Low
Report
Form SC 13G Outlook Therapeutics, Filed by: GREAT POINT PARTNERS LLC
4/8
06:03 am
otlk
Form EFFECT Outlook Therapeutics,
Low
Report
Form EFFECT Outlook Therapeutics,
4/2
04:16 pm
otlk
Form 8-K Outlook Therapeutics, For: Apr 01
Medium
Report
Form 8-K Outlook Therapeutics, For: Apr 01
4/2
06:05 am
otlk
Form EFFECT Outlook Therapeutics,
Medium
Report
Form EFFECT Outlook Therapeutics,
4/1
04:54 pm
otlk
Form 424B3 Outlook Therapeutics,
Medium
Report
Form 424B3 Outlook Therapeutics,
3/29
02:17 pm
otlk
Form D Outlook Therapeutics,
High
Report
Form D Outlook Therapeutics,
3/29
10:39 am
otlk
Form 4 Outlook Therapeutics, For: Mar 28 Filed by: Haddadin Yezan Munther
High
Report
Form 4 Outlook Therapeutics, For: Mar 28 Filed by: Haddadin Yezan Munther
3/28
05:08 pm
otlk
Form S-8 Outlook Therapeutics,
High
Report
Form S-8 Outlook Therapeutics,
3/28
05:04 pm
otlk
Form S-3 Outlook Therapeutics,
High
Report
Form S-3 Outlook Therapeutics,
3/28
04:23 pm
otlk
Form SC 13G Outlook Therapeutics, Filed by: Velan Capital Investment Management LP
High
Report
Form SC 13G Outlook Therapeutics, Filed by: Velan Capital Investment Management LP
3/28
04:01 pm
otlk
Form SC 13G Outlook Therapeutics, Filed by: TANG CAPITAL PARTNERS LP
High
Report
Form SC 13G Outlook Therapeutics, Filed by: TANG CAPITAL PARTNERS LP
3/26
04:20 pm
otlk
Form 8-K Outlook Therapeutics, For: Mar 20
Medium
Report
Form 8-K Outlook Therapeutics, For: Mar 20
3/25
04:12 pm
otlk
Form S-3 Outlook Therapeutics,
Low
Report
Form S-3 Outlook Therapeutics,
3/22
05:01 pm
otlk
Form 4 Outlook Therapeutics, For: Mar 20 Filed by: Evanson Jeff
Low
Report
Form 4 Outlook Therapeutics, For: Mar 20 Filed by: Evanson Jeff
3/22
05:01 pm
otlk
Form 4 Outlook Therapeutics, For: Mar 20 Filed by: KENYON LAWRENCE A
Low
Report
Form 4 Outlook Therapeutics, For: Mar 20 Filed by: KENYON LAWRENCE A
3/22
05:00 pm
otlk
Form 4 Outlook Therapeutics, For: Mar 20 Filed by: TRENARY C RUSSELL III
Low
Report
Form 4 Outlook Therapeutics, For: Mar 20 Filed by: TRENARY C RUSSELL III
3/20
05:24 pm
otlk
Form SC 13D/A Outlook Therapeutics, Filed by: GMS Ventures & Investments
Medium
Report
Form SC 13D/A Outlook Therapeutics, Filed by: GMS Ventures & Investments
3/20
05:20 pm
otlk
Form 4 Outlook Therapeutics, For: Mar 18 Filed by: Sukhtian Ghiath M.
Medium
Report
Form 4 Outlook Therapeutics, For: Mar 18 Filed by: Sukhtian Ghiath M.